Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Teva
Harvard Business School
Moodys
Boehringer Ingelheim
AstraZeneca
Dow
UBS

Generated: December 11, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Vesprin

« Back to Dashboard

Bulk Pharmaceutical API Sources for Vesprin

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ➤ Try a Free Trial 5568 ➤ Try a Free Trial
AAA Chemistry ➤ Try a Free Trial AR-1K7464 ➤ Try a Free Trial
ABI Chem ➤ Try a Free Trial AC1L1KMZ ➤ Try a Free Trial
ABI Chem ➤ Try a Free Trial AC1Q4JZU ➤ Try a Free Trial
Chembase.cn ➤ Try a Free Trial 390 ➤ Try a Free Trial
Mcule ➤ Try a Free Trial MCULE-9151902507 ➤ Try a Free Trial
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Deloitte
Cerilliant
Chubb
UBS
Baxter
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.